Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Cystic Fibrosis
NCT01132482Phase 2Completed
- Sponsor
- National Jewish Health
- Start
- Oct 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in cystic fibrosis (CF), sponsored by National Jewish Health. Started Oct 2015; status: completed.
02
Drugs
ASP-001
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01132482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132482.